In this study, by analyzing the data of the Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA), we found tenascin-C (TNC) was associated with the prognosis of LGG patients and could reflect the status of the tumor immune microenvironment. Here, TNC is linked to central nervous system cancer.